Seroatlas · Human Serome Atlas

FCGR2A

Low affinity immunoglobulin gamma Fc region receptor II-a

Also known as: CD32, CD32A, CDw32, Fc-gamma-RIIa, FCG2, FCG2A_HUMAN, FcgammaRIIa, FCGR2, FCGR2A1, IGFR2

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P12318
Gene
FCGR2A
Ensembl
ENSG00000143226
Chromosome
1
Canonical length
317 aa
Protein class
CD markers, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins
Subcellular location
Golgi apparatus,Plasma membrane

OverviewNCBI Gene

This gene encodes one member of a family of immunoglobulin Fc receptor genes found on the surface of many immune response cells. The protein encoded by this gene is a cell surface receptor found on phagocytic cells such as macrophages and neutrophils, and is involved in the process of phagocytosis and clearing of immune complexes. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2008]

Canonical amino-acid sequenceUniProt

317 residues, UniProt reviewed canonical sequence.

>P12318|FCGR2A
     1  MTMETQMSQN VCPRNLWLLQ PLTVLLLLAS ADSQAAAPPK AVLKLEPPWI NVLQEDSVTL
    61  TCQGARSPES DSIQWFHNGN LIPTHTQPSY RFKANNNDSG EYTCQTGQTS LSDPVHLTVL
   121  SEWLVLQTPH LEFQEGETIM LRCHSWKDKP LVKVTFFQNG KSQKFSHLDP TFSIPQANHS
   181  HSGDYHCTGN IGYTLFSSKP VTITVQVPSM GSSSPMGIIV AVVIATAVAA IVAAVVALIY
   241  CRKKRISANS TDPVKAAQFE PPGRQMIAIR KRQLEETNND YETADGGYMT LNPRAPTDDD
   301  KNIYLTLPPN DHVNSNN

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against FCGR2A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
1
Mean surface accessibility (rSASA)
0.45
Highest tissue expression
127 nTPM

Expression across tissuesHPA

Tissue

  • placenta: 127 nTPM
  • appendix: 113 nTPM
  • lung: 87 nTPM
  • urinary bladder: 77 nTPM
  • adipose tissue: 75 nTPM
  • bone marrow: 52 nTPM

Single-cell type

  • neutrophils: 452 nCPM
  • macrophages: 110 nCPM
  • monocytes: 109 nCPM
  • cdc: 61 nCPM
  • late spermatids: 57 nCPM
  • microglia: 51 nCPM

Immune cell

  • neutrophil: 2,531 nTPM
  • eosinophil: 451 nTPM
  • classical monocyte: 398 nTPM
  • intermediate monocyte: 301 nTPM
  • non-classical monocyte: 264 nTPM
  • total PBMC: 189 nTPM

Brain region

  • white matter: 48 nTPM
  • medulla oblongata: 32 nTPM
  • thalamus: 31 nTPM
  • choroid plexus: 29 nTPM
  • pons: 25 nTPM
  • spinal cord: 24 nTPM

ReferencesPubMed · IEDB

Publications for FCGR2A from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.

Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.35
gnomAD pLI
0
gnomAD missense Z
0.35
DepMap mean gene effect
0.09
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of FCGR2A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads FCGR2A as an antibody target. Whether an autoantibody or antibody against FCGR2A could matter depends on whether native FCGR2A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

FCGR2A is annotated at the cell surface, where native FCGR2A is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label FCGR2A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/FCGR2A. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...